Exploring the role of ELOVLs family in lung adenocarcinoma based on bioinformatic analysis and experimental validation
Our study indicated that ELOVL6 could be used as an indicator to evaluate the prognosis and therapeutic effect, and even potential therapeutic target for patients with LUAD.
Authors
- Wenjing Cui (ORCID: https://orcid.org/0000-0003-1308-1404)
- Yifan Qiu
- Long Liang (ORCID: https://orcid.org/0000-0001-7193-8547)
- Yongchang Sun (ORCID: https://orcid.org/0000-0003-3281-8854)
- Ying Luo (ORCID: https://orcid.org/0000-0002-1325-2296)
- Yue Zhang (ORCID: https://orcid.org/0000-0001-6984-3047)
- Zihan Wang (ORCID: https://orcid.org/0000-0001-7563-3839)
- Danyang Li (ORCID: https://orcid.org/0009-0007-9722-8798)
- Jingge Qu (ORCID: https://orcid.org/0000-0003-4026-1320)
- Yuqiang Pei
Institutions
- Shandong University (CN)
- Peking University (CN)
- Peking University Third Hospital (CN)
- Shandong Provincial QianFoShan Hospital (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-01-10
- DOI
- https://doi.org/10.1186/s12885-024-13415-y
- Citations
- 1
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.94
Funders
- National Natural Science Foundation of China